Electrocardiographic and Electrophysiologic Changes After Percutaneous Closure of Atrial Septal Defect
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAssiut University
About this trial
Primary outcomes :
Determining the incidence of SAN and AVN dysfunction before and after percutaneous ASD closure Comparing ECG and EP parameters of SAN and AVN before and after percutaneous ASD closure
Secondary outcomes :
Assessing clinical, echocardiographic and procedural risk factors affecting the AVN function after ASD closure device implantation Determining the incidence of supraventricular arrhythmia inducibility before and after percutaneous ASD closure
Eligibility criteria
Qualifiers
All patients presented with secundum ASD eligible for percutaneous transcatheter ASD closure at Assiut university heart hospital
Disqualifiers
No exclusion
Trial design
Treatments tested in this trial
- Electrophysiology study of heart
Treatment groups
65 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov